Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 1463

Phoenix, AZ 85013


Study Summary:

We are conducting a Phase I evaluation of the safety and pharmacokinetic equivalence to WinRho SDF of a new intravenous anti-D immunoglobulin preparation (Nabi Anti-D)


Qualified Participants Must:

• Be Rh (D)-negative
• Be male or female 18-55 years of age
• Be healthy subjects defined as individuals who are free from significant current cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, neurological, pyschiactric or other disease based upon history, physical examination and clinical laboratory test results.


Qualified Participants May Receive:

Study-related medical care, study medication, and compensation for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.